Bellevue Group AG

SEC CIK: 0001674546
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RLMD holding history

Relmada Therapeutics, Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RLMD overview All 13F holders of RLMD Full Q2 2026 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2022

Holdings of RLMD by Bellevue Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−53,187−100.0%	Sold out	Holders
Q3 2022	53,187	$1.97M	<0.1%	+18,187+52.0%	Added	Holders
Q2 2022	35,000	$665.0K	<0.1%	+19,000+118.8%	Added	Holders
Q1 2022	16,000	$432.0K	<0.1%	+16,000	New	Holders